|1.||Troisi, Rebecca: 15 articles (02/2014 - 10/2002)|
|2.||Hatch, Elizabeth E: 15 articles (02/2014 - 10/2002)|
|3.||Palmer, Julie R: 14 articles (02/2014 - 10/2002)|
|4.||Herbst, Arthur L: 13 articles (04/2015 - 10/2002)|
|5.||Titus-Ernstoff, Linda: 13 articles (02/2014 - 10/2002)|
|6.||Robboy, Stanley J: 11 articles (04/2015 - 01/2005)|
|7.||Noller, Kenneth L: 10 articles (10/2011 - 10/2002)|
|8.||Hoover, Robert N: 10 articles (10/2011 - 10/2002)|
|9.||Adam, Ervin: 9 articles (04/2015 - 03/2003)|
|10.||Newbold, Retha R: 9 articles (10/2013 - 09/2002)|
|1.||Prostatic Neoplasms (Prostate Cancer)
02/01/2013 - "The purpose of this study was to assess the efficacy and safety of low-dose (1 mg) daily diethylstilbestrol (DES) for the treatment of castrate-resistant prostate cancer (CRPC). "
12/01/2012 - "The aim of this review was to describe the most recent data from contemporary clinical trials of diethylstilbestrol (DES) to better determine its current role in advanced prostate cancer treatment as new hormonal therapies emerge. "
06/01/1986 - "As far as prostatic cancer is concerned, data coming from comparative trials show that MPA is less effective than diethylstilbestrol (DES), and therefore should not be considered the first choice for previously untreated patients. "
02/01/1962 - "A cooperative group study of prostatic cancer: stilbestrol versus placebo in advanced progressive disease."
05/01/2013 - "Diethylstilbestrol (DES) has a direct cellular mechanism inhibition on prostate cancer. "
01/01/1981 - "Tumors grown in hypophysectomized, orchiectomized, adrenalectomized, or diethylstilbestrol-treated animals showed a significant reduction in the proportion of mid-S phase cells as compared with controls. "
01/01/2006 - "In the present study, we investigated HLTF expression by immunohistochemistry in a model of kidney tumors induced by continuous administration of diethylstilbestrol to male Syrian golden hamsters. "
08/01/2005 - "This study explores in what ways the genotoxic, cytotoxic and apoptotic effects of diethylstilbestrol (DES), a chemical agent currently used in the treatment of various types of cancer, on the human lymphocytes depend upon the dose and the exposure time. "
07/01/2004 - "Studies with clastogenic carcinogen diethylstilbestrol (DES) resulted in a broad of spectrum of toxic and carcinogenic effects in humans and rodents, but the cellular and molecular mechanism(s) by which it induces cancer is not clear. "
01/01/1986 - "Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate."
01/01/2005 - "Diethylstilbestrol (DES) is a synthetic compound with potent estrogenic actions useful in the treatment of prostate carcinoma despite the fact that it can also induce some forms of neoplasia. "
05/01/2014 - "Non-diethylstilbestrol-associated primary clear cell carcinoma of the vagina: two case reports with immunohistochemical studies and literature review."
10/01/1981 - "Since 1971 several studies have reported the appearance of clear-cell carcinoma and clear-cell cervical carcinoma in young women exposed prenatally to diethylstilbestrol (DES). "
08/01/2014 - "We report a rare case of clear cell carcinoma of cervix (CCCC) in a 60-year-old Asian female with no history of diethylstilbestrol (DES) ingestion. "
05/01/2014 - "Due to its widely proven role in the development of this carcinoma, administration of diethylstilbestrol is prohibited. "
|4.||Breast Neoplasms (Breast Cancer)
01/01/1963 - "[A CASE OF BREAST CANCER OF LONG DURATION "CURED" WITH STILBESTROL]."
10/01/1996 - "These findings are consistent with those of several other studies of diethylstilbestrol exposure and breast cancer."
10/01/1996 - "The age of study participants did not modify the association between exposure and breast cancer, and there were no significant interactions between ever use of diethylstilbestrol and any of the other potential risk factors included in the analysis. "
08/01/2015 - "However, in utero exposure to another xenoestrogen, diethylstilbestrol, predicts an increased breast cancer risk. "
01/01/2015 - "In utero exposure to diethylstilbestrol (DES) has been associated with increased risk of adverse health outcomes such as fertility problems and vaginal as well as breast cancer. "
07/01/1986 - "This paper reports on a study of four cases of primary adenocarcinoma (including one with in utero diethylstilbestrol exposure) of the vagina from the files of the Medical University of South Carolina. "
06/01/1980 - "A study was done on 30 patients with advanced adenocarcinoma of the prostate treated with diethylstilbestrol. "
12/01/2012 - "To investigate if ERΔ3 expression influences uterine carcinogenesis, ERΔ3 transgenic mice were exposed to diethylstilbestrol (DES) on post-natal days 1-5. Neonatal DES treatment induced uterine adenocarcinomas in 81% of 8-month-old ERΔ3 mice compared to 49% of wild-type females (p<0.016). "
03/01/2012 - "At least 9 other examples of primary vaginal, or more uncommonly cervical, adenocarcinomas arising in non-diethylstilbestrol-exposed women with congenital genitourinary malformations have been reported, suggesting a probable causal association between congenital malformation, vaginal adenosis, and vaginal adenocarcinoma."
03/01/2012 - "In reporting these cases, we discuss atypical adenosis and other types of non-diethylstilbestrol-associated vaginal adenocarcinomas. "
|5.||Gonadotropin-Releasing Hormone (GnRH)
|2.||Drug Therapy (Chemotherapy)
|5.||Palliative Care (Palliative Medicine)